Table 2.
Problems identified in medication review reports and recommendations of medication changes based on medication reviews and primary healthcare team discussions
| Problems identified in medication review reports | % of problems N = 602 |
|---|---|
| Condition caused by adverse drug reaction | 16.9% |
| Sub-optimal monitoring | 16.3% |
| Label discrepancy/other adherence difficulties, e.g. drug not taken as indicated by label or in patient profile (apparent non-concordance), under or overuse reported by patient, administration aid or device not effective | 12.8% |
| Disorder treated with wrong (or suboptimal) drug | 9.3% |
| Over- or subtherapeutic dosage of correct drug | 9.3% |
| Condition caused by drug–drug, drug–food, drug–laboratory test interaction | 9.1% |
| Other | 7.8% |
| Untreated indication | 6.3% |
| Sub-optimal drug administration | 3.8% |
| Drug use without valid medical indication | 3.5% |
| Poor medication knowledge | 1.7% |
| Medication hoarding or poor storage of medication | 2.5% |
| Problem associated with drug supply | 0.5% |
| No problem stated | 0.2% |
| Actions suggested following medication reviews and primary health care team discussions | % of actions suggested N = 747 |
| Monitoring – laboratory | 21.0% |
| Change drug – substitute one drug for another | 12.6% |
| Other, e.g. resolve non-concordance between patient-reported and GP-recorded drug regimen (4.4% of N); further investigation of potential ADE (1.6% of N) | 11.9% |
| Provision of patient (or carer) education or information | 10.4% |
| Cease drug or trial withdrawal to confirm need for treatment | 9.5% |
| Change dose, dosage interval or frequency | 8.7% |
| Add a drug | 6.4% |
| No recommendation made | 6.4% |
| Monitoring observation and non-lab monitoring | 5.0% |
| Change administration time, route or dose form | 3.5% |
| Rationalize medications held in the home | 1.7% |
| Non-drug therapy suggested | 1.5% |
| Other intervention to improve adherence | 0.8% |
| Refer patient to another professional | 0.5% |
Feedback for 110 patients. Note there are more recommendations than problems, because the reviewing pharmacist sometimes suggested a range of possible interventions.